Effects of selective serotonin reuptake inhibitors (SSRIs) on suicide: A network meta-analysis of double-blind

Yuling Li1, Chengfeng Chen1, Qinghua Chen1

  • 1The Mental Health College of Guangzhou Medical University, Guangzhou, PR China; Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, PR China.

Psychiatry Research
|April 25, 2024
PubMed

Insights

Selective serotonin reuptake inhibitors (SSRIs) show short-term protection against suicidal thoughts in mental health patients. However, their long-term effectiveness in reducing suicidal ideation and behavior is limited.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • The association between selective serotonin reuptake inhibitors (SSRIs) and suicide risk in individuals with mental disorders is a subject of ongoing debate.
  • Understanding the precise impact of SSRIs on suicidal ideation and behavior is crucial for effective mental health treatment.

Purpose of the Study:

  • To conduct a network meta-analysis evaluating the effects of SSRIs on suicide risk in patients diagnosed with mental disorders.
  • To synthesize evidence from double-blind randomized trials to clarify the efficacy of SSRIs in managing suicidal ideation and behavior.

Main Methods:

  • A comprehensive literature search was performed across major databases (PubMed, Web of Science, PsycINFO, CENTRAL, Wanfang, CNKI) up to December 19, 2023.
  • Included 29 double-blind randomized trials focusing on suicidal ideation and suicidal behavior as primary outcomes.
  • Network meta-analysis was employed to compare SSRIs, non-SSRIs, and placebo treatments.

Main Results:

  • SSRIs demonstrated a short-term protective effect against suicidal ideation by week 2, with paroxetine, fluoxetine, and escitalopram showing significant risk reduction compared to placebo (sertraline was an exception).
  • This protective effect on suicidal ideation diminished by week 8.
  • No significant differences in efficacy were observed between SSRIs, non-SSRIs, and placebo for instances of suicidal behavior between weeks 1 and 10.

Conclusions:

  • SSRIs may provide transient protection against suicidal ideation in patients with mental disorders.
  • The long-term efficacy of SSRIs in mitigating suicidal ideation and preventing suicidal behaviors appears limited.
  • Further research may be needed to explore alternative or adjunctive strategies for long-term suicide risk management in this population.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
377
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
459
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.5K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
71
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
84